CAS RN: 1577222-14-0
4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
Product Availability
Choose a grade to view its available package options.
2 package records 1 with current stock 2 grade groups
Grade
95% (1)
98% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250107
50mg / 100mg / 250mg / 1g
Confirm by inquiry
Shanghai 5-7 business days Inquiry
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260625
5mg / 25mg / 100mg
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1577222-14-0
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
1577222-14-0 / 4-O-[2-(2,5-dioxopyrrolidin-1-yl)ethyl] 1-O-methyl (E)-but-2-enedioate
Standard CAS: 1577222-14-0
Multi CAS: No
Basic Information
copy
CAS
1577222-14-0 copy
Multi CAS
No copy
Molecular Formula
C11H13NO6 copy
Molecular Weight
255.220000 copy
Exact Mass
255.074287 copy
SMILES
COC(=O)/C=C/C(=O)OCCN1C(=O)CCC1=O copy
InChI
InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+ copy
InChIKey
YIMYDTCOUQIDMT-SNAWJCMRSA-N copy
Physical Properties
copy
Melting Point
102-106 copy
Boiling Point
192-193 copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Fraction Csp3
0.45 copy
Rotatable bonds
5 copy
H-bond acceptors
6 copy
Molar refractivity
58.07 copy
TPSA
89.98 copy
LogP / Solubility
WLOGP
-0.59 copy
MLOGP
-0.51 copy
XLogP3
-0.9 copy
Consensus LogP
-0.67 copy
Log S (ESOL)
-0.72 copy
Class (ESOL)
Very soluble copy
Log S (Ali)
-1.23 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.43 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.7 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. copy